Senna
alexandrina. Cassia angustifolia, C. acutifolia,
C. senna 番泻叶 Fān xiè yè
Senna leaf Family:
LeguminosaeCassia angustifolia:
round leaved- Tinnevelly senna, Indian senna.
Cassia acutifolia: pointed leaved- Alexandrian senna, Khartoum senna. The Arabic word ‘senna’ and the Hebrew word ‘Cassia’
meaning “peeled back” (with reference to its peelable bark) together gave this
plant its name. It has been used in ayurvedic and unani medicines since the ninth
century. See also, Seeds
of Senna PART USED: Leaf- harvested
before the lowers bloom- C. angustifolia, or in Autumn when the fruit has ripened-
C. acutifolia. FLAVOR: Sweet, bitter. CHANNEL:
Large Intestine FUNCTIONS GROUP: Descending- Cooling
purgatives
1. Drains downward and guides out stagnation.[1,3]
Purgative (acts in about 2-3 hours). Speeds up peristalsis of the intestines-
usually open bowels several times.[2] INDICATIONS
1. Constipation due to Heat in the Intestines.[1,2,3]
2. Accumulation of food.[1,2] Abdominal
fullness.[1,2] Accumulation of water
in abdomen (ascites).[1,2] Overeating
and indigestion.[1] NOTE: Fan xie ye must be combined with Qi regulating and Wind dispersing
herbs, such as Huo xiang and Xiang
fu to prevent side effects of stomach pain and vomiting.[2]In Southern China, this herb is takne as a tea to prevent Summer Heat disorders.[3]
CONTRAINDICATIONS: Pregnancy, menstruation, and after childbirth during lactation.[3]
Intestinal infections- as they will get worse. Old and weak patients suffering
from chronic contipation.[3] Hemorrhoids.[2] COMBINATIONS
PREPARATIONS: Small
Dry leaves. Decoction 1-4 g, when steeped as tea.[1,
2,3] For laxative 3-9 g.[2,3]
Do not cook for more than 15 minutes.[3]
Overdose may result in abdominal pain, nausea, and vomiting.[3]
Good quality has narrow green leaves.
ORIGIN: Tropical Africa and culivated in Egypt and the Sudan.
References
[1] Barefoot Doctor's Manual- 1977 Prepared
by the Revolutionary Health Committee of Hunan Province. Original Chinese manual-
Victor W. Sidel. Originally published by Dr Joseph Quin and the Fogarty International
centre, Bethdesda (1974). Madrona Publishers Seattle Washington ISBN 0-914842-52-8
[2] Translation notes from Gary Seiford and Hocu Huhn- NSW College of Natural
Therapies. Sydney Australia (1982).
[3] Chinese Herbal Medicine Materia Medica- Dan Bensky and Andrew Gamble- Eastland
Press 1986 Seattle Washington ISBN 0-939616-15-7 Images
1. en.wikipedia.org
by Vinayaraj CC BY 2.0
2. old.tcmwiki.com
3. urbanfringe.co.uk
4. stage2.earth.com
Inner Path can not take any responsibility for any adverse effects from the
use of plants. Always seek advice from a professional before using a plant medicinally. Constituents.
Pods: Anthraquinone glycosides-
Alexandrian pods contain 2% hydroxyanthraquinone sennoside B.[1] Leaves: Anthraquinone glycosides- 2-3% hydroxy-anthraquinone sennoside
A and B based on the alglycones sennidin A and sennidin B.[3,4,5,6,7]
Sennosides C and D which are glycosides of heterodianthrones of aloe-emodin
and rhein.[3,4,5,6,7]
The aglycone of sennoside A is dextrorotary while that of sennoside B is the
meso-form. Rhein, chrysophanol, chrysophanic acid, aloemodin, emodin glucoside.[3] C. senna usually contains greater amounts of the sennosides. In the
fruit; sennosides A and B and a closely related glycoside sennoside A1.[8]
Napthalene glycosides; tinnevellin glycoside and 6-hydroxymusizin glycoside,
in both leaves and pods.[9]
Mucilage, flavonoids, volatile oil, sugars, resins.[10] References
[1] British Herbal Pharmacopoeia 1983 Published by the British Herbal Medicine
Association ISBN 0 903032 07 4.
[2] Chinese Herbal Medicine Materia Medica- Dan Bensky and Andrew Gamble- Eastland
Press 1986 Seattle Washington ISBN 0-939616-15-7
[3] Van Os, F.H. L. (1976) Pharmacol. 14 (Suppl. 1), 7
[4] Fairbairn, J.W. (1976) Pharmacol. 14 (Suppl.1), 48
[5] Fairbairn, J. W. (1964) Lloydia 27, 79
[6] Fairbairn, J.W. and Shresha, A.B. (1967) Lloydia 30, 67
[7] Lemli, J. and Cuveele, J. (1975) Phytochem. 14, 1397
[8] Christ, B. et al. (1978) Arzneim. Forsch. 28, 225
[9] Lemli, J. et al. (1981) Planta Med. 43, 11
[10] Encyclopedia of Common Natural Ingredients used in Food Drugs and Cosmetics,
Albert Y. Leung. Pub. John Wiley & sons Inc. (1980) NY
Research.
The glycosides are absorbed from the intestinal tract and the active anthraquinones
excreted into the colon wher they exert their stimulant effect.
Senna alexandrina extract supplementation reverses hepatic oxidative,
inflammatory, and apoptotic effects of cadmium chloride administration in rats
Xianbin Wang, Ting Wang, Tingting Pan, Mei Huang, Weihua Ren, Geliang Xu, Hatem
K Amin, Rami B Kassab, Ahmed E Abdel Moneim Abstract
Senna alexandrina is traditionally used for its antioxidant and anti-inflammatory
properties, but little information is available concerning its potential protective
effects against cadmium, which is a widespread environmental toxicant that causes
hepatotoxicity. Here, we explored the effects of S. alexandrina extract (SAE)
on cadmium chloride (CdCl2)-induced liver toxicity over 4 weeks in rats. Rats
were allocated into four groups: control, SAE (100 mg/kg), CdCl2 (0.6 mg/kg),
and SAE + CdCl2, respectively. Cadmium level in hepatic tissue, blood transaminases,
and total bilirubin as indicators of liver function were assessed. Oxidative stress
indices [malondialdehyde (MDA), nitrate/nitrite (NO), and glutathione (GSH)],
antioxidant molecules [superoxide dismutase (SOD, catalase (CAT), glutathione-derived
enzymes, and nuclear factor erythroid 2-related factor 2 (Nrf2)], pro-inflammatory
mediators [interleukin-1 beta (IL-1ß) and tumor necrosis factor-alpha (TNF-a)],
apoptosis proteins (Bcl-2, Bax, and caspase-3), and histological alterations to
the liver were examined. SAE administration before CdCl2 exposure decreased cadmium
deposition in liver tissue and the blood liver function indicators. SAE pre-treatment
prevented oxidative, inflammatory, and apoptotic reactions and decreased histological
alterations to the liver caused by CdCl2 exposure. SAE can be used as a promising
protective agent against CdCl2-induced hepatotoxicity by increasing Nrf2 expression.
Graphical abstract.
Environ Sci Pollut Res Int 2020 Feb;27(6):5981-5992. Epub 2019 Dec 20. PMID: 31863371
DOI: 10.1007/s11356-019-07117-3 pubmed.ncbi.nlm.nih.gov
Is senna laxative use associated to cathartic colon, genotoxicity, or
carcinogenicity?
M A Morales, D Hernández, S Bustamante, I Bachiller, A Rojas Abstract
Due to their natural origin, apparent low oral toxicity, effectiveness, and accessibility
without a medical prescription, the anthranoid laxatives are a popular remedy
for constipation and are frequently used abusively. Therefore, it is important
to characterize its harmful and/or toxic effects. The sennosides, main active
metabolites of senna, exhibit a very low toxicity in rats, and its genotoxic activity
in bacterial strains as well as mammal cells was classified as weak in those cases
where it was shown to be significant. The toxicological and mutagenic status of
the crude extract of senna, however, is not as well characterized, and it is necessary
to do so since it is frequently, and at the same time incorrectly, believed that
the chronic use of anthranoid laxatives is a risk factor for the development of
colorectal cancer. The objective of this article was to review the information
that arises in various scientific medical databases using key words such as senna,
sen, Senna alexandrina, Cassia angustifolia, sennosides, laxative toxicity, mainly
ISI and non-ISI articles of journals with an editorial committee. Web pages of
products or companies that publicize or commercialize this type of laxative were
not included. This analysis establishes that (1) there is no convincing evidence
that the chronic use of senna has, as a consequence, a structural and/or functional
alteration of the enteric nerves or the smooth intestinal muscle, (2) there is
no relation between long-term administration of a senna extract and the appearance
of gastrointestinal tumors or any other type in rats, (3) senna is not carcinogenic
in rats even after a two-year daily dose of up to 300 mg/kg/day, and (4) the current
evidence does not show that there is a genotoxic risk for patients who take laxatives
containing senna extracts or sennosides.
J Toxicol 2009;2009:287247. Epub 2009 Sep 10. PMID: 20107583 PMCID: PMC2809429
DOI: 10.1155/2009/287247 pubmed.ncbi.nlm.nih.gov